Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.

Authors : Kirchhof P; Lip GY; Van Gelder IC; Bax J; Hylek E; Kaab S; Schotten U; Wegscheider K; Boriani G; Brandes A; Ezekowitz M; Diener H; Haegeli L; Heidbuchel H; Lane D; Mont L; Willems S; Dorian P; Aunes-Jansson M; Blomstrom-Lundqvist C; Borentain M; Breitenstein S; Brueckmann M; Cater N; Clemens A; Dobrev D; Dubner S; Edvardsson NG; Friberg L; Goette A; Gulizia M; Hatala R; Horwood J; Szumowski L; Kappenberger L; Kautzner J; Leute A; Lobban T; Meyer R; Millerhagen J; Morgan J; Muenzel F; Nabauer M; Baertels C; Oeff M; Paar D; Polifka J; Ravens U; Rosin L; Stegink W; Steinbeck G; Vardas P; Vincent A; Walter M; Breithardt G;

Affiliations : University Hospital Münster, Münster, Germany. Corresponding author. Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de

Journal : Europace   (2011)

Related Links: Pubmed | Publisher website

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Authors : Savelieva I; Kakouros N; Kourliouros A;

Affiliations : Corresponding author. Tel: +44 20 8725 0439; fax: +44 20 8725 3416, Email: isavelie@sgul.ac.uk

Journal : Europace   (2011)

Related Links: Pubmed | Publisher website

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Authors : Savelieva I; Kakouros N; Kourliouros A;

Affiliations : Division of Cardiac and Vascular Sciences, St George's University of London, London SW17 0RE, UK. isavelie@sgul.ac.uk Tel: +44 20 8725 0439; fax: +44 20 8725 3416, Email: isavelie@sgul.ac.uk

Journal : Europace   (2011)

Related Links: Pubmed | Publisher website

Regulatory pathways for development of antiarrhythmic drugs for management of atrial fibrillation/flutter†

Authors : Savelieva I; Kirchhof P; Danchin N; de Graeff PA;

Affiliations : Division of Cardiac and Vascular Sciences, St George's University of London, London, UK. isavelie@sgul.ac.uk Tel: +44 20 8725 0439; fax: +44 20 8725 3416, Email: isavelie@sgul.ac.uk

Journal : EP Europace   (2011)

Related Links: Pubmed | Publisher website

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Authors : Savelieva I; Kakouros N; Kourliouros A;

Affiliations : Division of Cardiac and Vascular Sciences, St George's University of London, London SW17 0RE, UK. isavelie@sgul.ac.uk Corresponding author. Tel: +44 20 8725 0439; fax: +44 20 8725 3416, Email: isavelie@sgul.ac.uk

Journal : Europace   (2011)

Related Links: Pubmed | Publisher website

Regulatory pathways for development of antiarrhythmic drugs for management of atrial fibrillation/flutter†

Authors : Savelieva I; Kirchhof P; Danchin N; de Graeff PA;

Affiliations : Division of Cardiac and Vascular Sciences, St George's University of London, London, UK. isavelie@sgul.ac.uk Tel: +44 20 8725 0439; fax: +44 20 8725 3416, Email: isavelie@sgul.ac.uk

Journal : EP Europace   (2011)

Related Links: Pubmed | Publisher website

Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?

Authors : Aliot E; Breithardt G; Brugada J; Camm J; Lip GY; Vardas PE; Wagner M; Atrial Fibrillation AWareness And Risk Education group; Atrial Fibrillation Association; European Heart Rhythm Association; Stroke Alliance for Europe;

Affiliations : Department des Maladies CardioVasculaires, CHU de Nancy - Hôpital Brabois, 54511 Vanoeuvre-lès-Nancy, Nancy, France. Tel: +33 3 83 15 32 96; fax: +33 3 83 15 38 56, Email: e.aliot@chu-nancy.fr

Journal : EP Europace   (2011)

Related Links: Pubmed | Publisher website

Ganglionated plexi ablation for longstanding persistent atrial fibrillation

Authors : Aliot E, Breithardt G, Brugada J, Camm J, Lip GY, Vardas PE, Wagner M; Atrial Fibrillation AWareness And Risk Education group; Atrial Fibrillation Association; European Heart Rhythm Association; Stroke Alliance for Europe;

Affiliations : Brabois Hospital, University Hospital of Nancy, Nancy, France. e.aliot@chu-nancy.fr Tel: +7 9139254858; fax: +7 3833324550, Email: e.pokushalov@gmail.com; pokush@mail.ru

Journal : EP Europace   (2011)

Related Links: Pubmed | Publisher website

The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

Authors : European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P;

Affiliations : St George's University of London, Cranmer Terrace, London SW17 ORE, UK. Tel: +44 20 8725 3414, Fax: +44 20 8725 3416, Email: jcamm@sgul.ac.uk The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of EP-Europace and the party authorized to handle such permissions on behalf of the ESC.

Journal : EP Europace   (2011)

Related Links: Pubmed | Publisher website

An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation

Authors :

Affiliations : Corresponding author. Tel: +44 20 8725 3414; fax: +44 20 8725 3416. Email: jcamm@sgul.ac.uk

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines

Authors :

Affiliations : Division of Clinical Sciences, St George's University of London, London, UK Medical Writers Group, LLC, New York, USA

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Authors :

Affiliations : University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Institute for Biomedical Research, 1st Floor, Room 136, Birmingham B15 2TT, UK University Hospital Münster, Münster, Germany AFNET, Germany CHU de Nancy, Nancy, France Duke University School of Medicine, Durham, NC, USA Fondazione Cardiocentro Ticino, Lugano, Switzerland St. Jude Medical, St. Paul, MN, USA Department of Cardiology, University of Leiden Medical Center, Leiden, NL, The Netherlands Department of Cardiology, Institution of Medical Science, Uppsala University, Uppsala, Sweden St. Antonius Hospital, Nieuwegein, The Netherlands University of Bologna, Bologna, Italy Odense University Hospital, Odense, Denmark Meda Pharma SAS, Paris, France University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany The Johns Hopkins Hospital, Baltimore, MD, USA University of Oxford, Oxford, UK University Hospital Maastricht, Maastricht, The Netherlands Daiichi Sankyo Europe GmbH, Munich, Germany University Duisburg-Essen, Essen, Germany Lankenau Institute for Medical Research, Wynnewood, PA, USA CRI—The Clinical Research Institute, Munich, Germany Ludwig Maximilian University, Munich, Germany University of Calgary/Libin, Calgary, Alberta, Canada Garibaldi-Nesima Hospital, Catania, Italy Bristol-Myers Squibb, Munich, Germany University Hospital Zurich, Zurich, Switzerland Faculté de Médecine Pitié-Salpêtrière, Paris, France Charité Berlin, Berlin, Germany University Hospital Gasthuisberg, Leuven, Belgium Hôpital Cardologique du Haut-Lévêque and the Université Victor Segalen Bordeaux II, Bordeaux, France University of Lausanne, Lausanne, Switzerland Institute for Clinical and Experimental Medicine, Prague, Czech Republic Klinik St. Georg, Hanseatisches Herzzentrum, Hamburg, Germany Isar Herzzentrum, Munich, Germany Medtronic International Trading Sàrl, Tolochenaz, Switzerland Hospital Clínic, University of Barcelona, Barcelona, Spain Pfizer Deutschland GmbH, Berlin, Germany Aarhus University Hospital, Aarhus, Denmark Städtisches Klinikum Brandenburg, Brandenburg, Germany Hacettepe University Faculty of Medicine, Ankara, Turkey Medizinische Universität Graz, Graz, Austria University of Belgrade, Belgrade, Serbia TU Dresden, Dresden, Germany Columbia University Medical Center, New York, NY, USA Bristol-Myers Squibb, Rueil-Malmaison, Paris, France Bayer Vital GmbH, Leverkusen, Germany St. Jude Medical, Zaventem, Belgium Boston Scientific, St. Paul, MN, USA Zentrum für Kardiologie am Klinikum Starnberg, Starnberg, Germany Institute of Cardiology, Warsaw, Poland Ettore Sansavini Health Science Foundation, Cotignola, Italy Ospedale dell'Angelo, Mestre-Venice, Venice, Italy Bayer Pharma AG, Berlin, Germany University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Sanofi Aventis Deutschland GmbH, Berlin, Germany University College Hospital, London, UK University Heart Center Hamburg, Hamburg, Germany St. George's Hospital Medical School, London, UK

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

2012 focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association

Authors :

Affiliations : A. John Camm, Division of Clinical Sciences, St.George's University of London, Cranmer Terrace, London SW17 0RE, United Kingdom

Journal : N/A   (2012)

Related Links: Pubmed | Publisher website